NEW YORK, Nov. 15, 2016 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) announces that Susan Bressman, MD, chair of the Department of Neurology at Mount Sinai Beth Israel, and Laurie Ozelius, PhD, associate neuroscientist and associate professor of neurology at Massachusetts General Hospital and Harvard Medical School, are recipients of the second annual Bachmann-Strauss Prize for Excellence in Dystonia Research. The researchers, who have collaborated for 30 years, were chosen for their work in dystonia genetics. "Drs. Bressman and Ozelius have made invaluable contributions to the field of dystonia research, an under-funded movement disorder and an under-recognized symptom of Parkinson's disease," said Bonnie Strauss, who founded The Bachmann-Strauss Dystonia & Parkinson Foundation, which launched a collaborative research alliance with MJFF in 2015. Michael J. Fox and MJFF senior vice president of research programs Brian Fiske, PhD, presented the prizes to Drs. Bressman and Ozelius at a ceremony in New York City on November 12, 2016. Learn more about the contributions of these researchers in a video on our website. The Bachmann-Strauss Prize for Excellence in Dystonia Research acknowledges dystonia researchers for key scientific discoveries and incentivizes the next generation of investigators to continue making inroads toward cures. Drs. Bressman and Ozelius's research has led to the identification of three primary or isolated dystonia genes, and they have built a repository of thousands of genes associated with dystonia. Their work also has yielded innovative imaging studies in families with these genetic associations. "Dystonia is the third most common movement disorder and has significant impact on the lives of those diagnosed and their families," said Dr. Bressman. "Dr. Ozelius and I are honored to be recognized with the Bachmann-Strauss Prize and even more so to be able to add to our understanding of this condition and, hopefully, its treatment."